What is bioAffinity Technologies's Price/Sales Ratio?

• bioAffinity Technologies's trailing twelve month (TTM) Price/Sales ratio is 3.36.
• bioAffinity Technologies's annual Price/Sales ratio as of today is 5.08.
• bioAffinity Technologies's quarterly Price/Sales ratio is 10.55.

What is the Price/Sales Ratio?

The Price/Sales ratio (P/S ratio) is a valuation metric that compares a company's stock price to its revenues. A lower P/S ratio may indicate that a stock is undervalued.

How is the Price/Sales Ratio calculated?

The Price/Sales ratio is calculated by dividing the company's market capitalization by its total sales or revenue. The formula is:

P/S Ratio = Market Capitalization / Total Sales (Revenue)

Related Metrics

Other important metrics to assess bioAffinity Technologies's financial health include:

• P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
  • Annual: -1.62
  • Quarterly: -3.00
  • TTM: -2.37
• P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
  • Annual: 2.65
  • Quarterly: 7.36
  • TTM: 6.04
• P/C Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
  • Annual: -2.13
  • Quarterly: -16.50
  • TTM: -2.95
• PEG Ratio (Price/Earnings to Growth Ratio) - measures the company's valuation considering its earnings growth:
  • Annual: 0.03
  • Quarterly: 0.60
  • TTM: -0.05

These metrics provide insights into bioAffinity Technologies's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

bioAffinity Technologies Historical Price/Sales Ratio

Historical P/E Ratio

Historical P/B Ratio

Historical P/C Ratio

Historical PEG Ratio